Clinical clostridium difficile: Clonality and pathogenicity locus diversity

Kate E. Dingle, David Griffiths, Xavier Didelot, Jessica Evans, Alison Vaughan, Melina Kachrimanidou, Nicole Stoesser, Keith A. Jolley, Tanya Golubchik, Rosalind M. Harding, Tim E. Peto, Warren Fawley, A. Sarah Walker, Mark Wilcox, Derrick W. Crook

Research output: Contribution to journalArticlepeer-review

144 Citations (Scopus)

Abstract

Clostridium difficile infection (CDI) is an important cause of mortality and morbidity in healthcare settings. The major virulence determinants are large clostridial toxins, toxin A (tcdA) and toxin B (tcdB), encoded within the pathogenicity locus (PaLoc). Isolates vary in pathogenicity from hypervirulent PCR-ribotypes 027 and 078 with high mortality, to benign non-toxigenic strains carried asymptomatically. The relative pathogenicity of most toxigenic genotypes is still unclear, but may be influenced by PaLoc genetic variant. This is the largest study of C. difficile molecular epidemiology performed to date, in which a representative collection of recent isolates (n = 1290) from patients with CDI in Oxfordshire, UK, was genotyped by multilocus sequence typing. The population structure was described using NeighborNet and ClonalFrame. Sequence variation within toxin B (tcdB) and its negative regulator (tcdC), was mapped onto the population structure. The 69 Sequence Types (ST) showed evidence for homologous recombination with an effect on genetic diversification four times lower than mutation. Five previously recognised genetic groups or clades persisted, designated 1 to 5, each having a strikingly congruent association with tcdB and tcdC variants. Hypervirulent ST-11 (078) was the only member of clade 5, which was divergent from the other four clades within the MLST loci. However, it was closely related to the other clades within the tcdB and tcdC loci. ST-11 (078) may represent a divergent formerly non-toxigenic strain that acquired the PaLoc (at least) by genetic recombination. This study focused on human clinical isolates collected from a single geographic location, to achieve a uniquely high density of sampling. It sets a baseline of MLST data for future comparative studies investigating genotype virulence potential (using clinical severity data for these isolates), possible reservoirs of human CDI, and the evolutionary origins of hypervirulent strains.

Original languageEnglish
Article numbere19993
JournalPLoS ONE
Volume6
Issue number5
DOIs
Publication statusPublished - 2011
Externally publishedYes

Bibliographical note

Funding Information:
We thank the staff of the Clinical Microbiology Laboratory and Infection Control, John Radcliffe Hospital, Oxford, and Infection Control Laboratory staff, Leeds General Infirmary, for their assistance throughout this work. This publication made use of the Clostridium difficile Multilocus Sequence Typing website, http://pubmlst.org/cdifficile/which uses the Bacterial Isolate Genome Sequence Database system developed by Keith Jolley and sited at the Department of Zoology, University of Oxford . The development of this site has been funded by the Wellcome Trust.

Fingerprint

Dive into the research topics of 'Clinical clostridium difficile: Clonality and pathogenicity locus diversity'. Together they form a unique fingerprint.

Cite this